Your browser doesn't support javascript.
loading
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.
Chang, Kwang-Yu; Chiang, Nai-Jung; Wu, Shang-Yin; Yen, Chia-Jui; Chen, Shang-Hung; Yeh, Yu-Min; Li, Chien-Feng; Feng, Xiaoxing; Wu, Katherine; Johnston, Amanda; Bomalaski, John S; Wu, Bor-Wen; Gao, Jianjun; Subudhi, Sumit K; Kaseb, Ahmed O; Blando, Jorge M; Yadav, Shalini S; Szlosarek, Peter W; Chen, Li-Tzong.
Afiliação
  • Chang KY; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chiang NJ; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Wu SY; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Yen CJ; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Chen SH; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Yeh YM; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Li CF; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Feng X; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Wu K; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Johnston A; Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.
  • Bomalaski JS; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Wu BW; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Gao J; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Subudhi SK; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Kaseb AO; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Blando JM; Polaris Pharmaceuticals, Inc., San Diego, California, USA.
  • Yadav SS; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Szlosarek PW; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen LT; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Oncoimmunology ; 10(1): 1943253, 2021.
Article em En | MEDLINE | ID: mdl-34290906
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Estados Unidos